Neutropenia
Neutropenia is a medical condition characterized by an abnormally low count of neutrophils, a crucial type of white blood cell, in the bloodstream. This reduction significantly impairs the body’s ability to fight off infections, making individuals more vulnerable to various pathogens.

Key Takeaways
- Neutropenia is defined by a low number of neutrophils, a vital white blood cell.
- It severely compromises the immune system, increasing the risk of infections.
- Common causes include chemotherapy, certain medications, and underlying medical conditions.
- Symptoms are primarily related to infections, such as fever and localized inflammation.
- Treatment focuses on addressing the root cause and preventing or managing infections.
What is Neutropenia?
Neutropenia refers to a condition where the absolute neutrophil count (ANC) in the blood falls below a certain threshold, typically less than 1,500 cells per microliter (µL). Neutrophils are a type of phagocyte, meaning they engulf and digest harmful bacteria and fungi, playing a critical role in the innate immune response. A low neutrophil count meaning a compromised immune system, as the body lacks its primary defenders against common pathogens. The severity of neutropenia is classified based on the ANC:
- Mild Neutropenia: ANC between 1,000 and 1,500 cells/µL
- Moderate Neutropenia: ANC between 500 and 1,000 cells/µL
- Severe Neutropenia: ANC less than 500 cells/µL
Individuals with severe neutropenia are at the highest risk for serious, life-threatening infections. According to the National Cancer Institute, febrile neutropenia, a common complication in cancer patients receiving chemotherapy, affects more than 60,000 patients annually in the United States, leading to significant morbidity and mortality if not promptly managed.
Neutropenia Causes and Symptoms
The development of neutropenia causes and symptoms can stem from a wide array of factors, ranging from temporary drug-induced effects to chronic underlying medical conditions. Understanding these causes is crucial for effective diagnosis and management. Common causes include:
- Chemotherapy and Radiation Therapy: These cancer treatments often suppress bone marrow activity, where neutrophils are produced.
- Certain Medications: Some antibiotics, antipsychotics, anti-seizure drugs, and anti-inflammatory medications can lead to drug-induced neutropenia.
- Bone Marrow Disorders: Conditions like aplastic anemia, myelodysplastic syndromes, and leukemia can impair neutrophil production.
- Autoimmune Diseases: Diseases such as lupus, rheumatoid arthritis, and Felty’s syndrome can cause the immune system to mistakenly attack and destroy neutrophils.
- Infections: Severe bacterial infections (sepsis), viral infections (HIV, hepatitis, influenza), and parasitic infections can sometimes lead to neutropenia.
- Nutritional Deficiencies: Severe deficiencies in vitamin B12 or folate can affect blood cell production.
- Congenital Conditions: Rare genetic disorders can result in chronic neutropenia from birth.
The primary symptom of neutropenia is an increased susceptibility to infections, which may manifest with subtle signs due to the body’s inability to mount a strong inflammatory response. Fever is often the most significant and sometimes the only indicator of an infection in a neutropenic patient. Other potential symptoms, often localized to the site of infection, include a sore throat or mouth sores, skin redness, swelling, or pus (abscesses), painful or frequent urination, cough or shortness of breath, diarrhea or abdominal pain, and unusual fatigue or general malaise.
Neutropenia Treatment Options
Effective management of neutropenia treatment options focuses on two main goals: addressing the underlying cause of the low neutrophil count and preventing or aggressively treating any infections that arise. The specific approach depends heavily on the cause and severity of the condition.
For drug-induced neutropenia, discontinuing the causative medication is often the first and most effective step. In cases related to chemotherapy, granulocyte colony-stimulating factors (G-CSFs), such as filgrastim or pegfilgrastim, are frequently used. These medications stimulate the bone marrow to produce more neutrophils, helping to shorten the duration and severity of neutropenia. For patients with severe or prolonged neutropenia, prophylactic antibiotics, antifungals, or antivirals may be prescribed to prevent infections.
When an infection is suspected, especially if accompanied by fever, immediate broad-spectrum antibiotic therapy is crucial, often before the specific pathogen is identified. This prompt treatment is vital to prevent rapid progression to severe sepsis or septic shock. In some cases, intravenous immunoglobulin (IVIG) or corticosteroids may be used, particularly in autoimmune-related neutropenia. For very rare and severe cases, bone marrow transplantation might be considered, though this is typically reserved for specific underlying conditions.
Beyond medical interventions, supportive care and patient education are paramount. This includes emphasizing meticulous hand hygiene, avoiding exposure to sick individuals, and maintaining good oral hygiene to reduce the risk of infection. Patients are often advised to monitor their temperature regularly and seek immediate medical attention for any signs of infection.



















